C07K 16/242
Lymphotoxin [lt]
Official title: {Lymphotoxin [LT]}
C07K16/242 (Lymphotoxin [lt]) appears on 23 US grants and 36 published applications in this corpus.
Search patents in C07K- Granted patents
- 23
- Published applications
- 36
- Assignees
- 21
- Inventors
- 70
- Latest grant
- 9 Jul 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 2 | 0 |
| 2002 | 1 | 1 |
| 2003 | 0 | 2 |
| 2004 | 0 | 1 |
| 2005 | 0 | 1 |
| 2006 | 1 | 2 |
| 2007 | 1 | 2 |
| 2008 | 1 | 1 |
| 2009 | 0 | 2 |
| 2010 | 0 | 1 |
| 2011 | 1 | 3 |
| 2012 | 3 | 2 |
| 2013 | 3 | 1 |
| 2014 | 1 | 1 |
| 2015 | 0 | 1 |
| 2016 | 0 | 0 |
| 2017 | 0 | 2 |
| 2018 | 0 | 1 |
| 2019 | 2 | 1 |
| 2020 | 1 | 1 |
| 2021 | 1 | 3 |
| 2022 | 1 | 0 |
| 2023 | 0 | 2 |
| 2024 | 1 | 3 |
| 2025 | 0 | 1 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Variant IgG Fc polypeptides and uses thereof9 Jul 2024US 12,030,945 B2Seismic Therapeutic, Inc.
- Antibody against human TGF-β LAP degradate, and use thereof1 Mar 2022US 11,261,244 B2Riken
- Modified antibodies containing modified IGG2 domains which elicit agonist or antagonistic properties and use thereof13 Jul 2021US 11,059,898 B2Cancer Research Technology Limited
- Process for manipulating the level of glycan content of a glycoprotein3 Nov 2020US 10,822,630 B2Amgen Inc.
- Compositions and methods for combating drug-resistant cancers17 Sep 2019US 10,413,564 B2National Yang-Ming University
- Process for manipulating the level of glycan content of a glycoprotein23 Apr 2026US 2026/0110013 A1Amgen Inc.
- Variant igg fc polypeptides and uses thereof6 Mar 2025US 2025/0074984 A1Seismic Therapeutic, Inc.
- Variant igg fc polypeptides and uses thereof11 Jul 2024US 2024/0228621 A9Seismic Therapeutic, Inc.
- Variant igg fc polypeptides and uses thereof25 Apr 2024US 2024/0132592 A1Seismic Therapeutic, Inc.
- T cell and antigen-presenting cell engagers and uses thereof8 Feb 2024US 2024/0041924 A1Nanjing Legend Biotech Co., Ltd.
Most cited
By later US patents
- Protein/(poly)peptide libraries350US 6,300,064 B1Morphosys AG · 2001
- Therapeutic using a bispecific antibody33US 6,458,933 B1Immunomedics, Inc. · 2002
- Lymphotoxin-β, lymphotoxin-β complexes, pharmaceutical preparations and therapeutic uses thereof21US 7,030,080 B2Biogen, Inc. · 2006
- Anti-lymphotoxin15US 4,959,457 AGenentech, Inc. · 1990
- Recombinant lymphotoxin cDNA and variants15US 5,824,509 AGenentech, Inc. · 1998